Pre-Existing Diabetes Limits Survival Rate After Immune Checkpoint Inhibitor Treatment for Advanced Lung Cancer: A Retrospective Study in Japan [Corrigendum]

Hisanaga K, Uchino H, Kakisu N, et al. Diabetes Metab Syndr Obes. 2021;14:773-781. Page 775, left column, third paragraph, line 4, the text "(p

Saved in:
Bibliographic Details
Published in:Diabetes, metabolic syndrome and obesity metabolic syndrome and obesity, 2021-07, Vol.14, p.3109-3110
Main Authors: Hisanaga, Kaori, Uchino, Hiroshi, Kakisu, Naoko, Miyagi, Masahiko, Yoshikawa, Fukumi, Sato, Genki, Isobe, Kazutoshi, Kishi, Kazuma, Homma, Sakae, Hirose, Takahisa
Format: Article
Language:English
Subjects:
Cancer
Care and treatment
Corrigendum
diabetes
Diabetes therapy
Drug therapy
immune checkpoint inhibitor
Lung cancer
Oncology, Experimental
overall survival
Patient outcomes
progression-free survival
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hisanaga K, Uchino H, Kakisu N, et al. Diabetes Metab Syndr Obes. 2021;14:773-781. Page 775, left column, third paragraph, line 4, the text "(p
ISSN:1178-7007
1178-7007
DOI:10.2147/DMSO.S319068